| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/18/1999 | CA1340542C Molecular cloning and characterization of a gene sequence coding for human relaxin |
| 05/14/1999 | WO1999023259A1 Antisense compounds to insulin-like growth factor-1 receptor |
| 05/14/1999 | WO1999023253A1 Stromal cell derived factor-1 (sdf-1) and method of use for diagnostic and prognostic indicator of aids pathogenesis |
| 05/14/1999 | WO1999023246A1 Methods and compositions for targeting dna metabolic processes using aminoglycoside derivatives |
| 05/14/1999 | WO1999023237A1 Transfecting peptide vector, composition containing same and applications |
| 05/14/1999 | WO1999023230A1 Reagents and methods useful for detecting diseases of the breast |
| 05/14/1999 | WO1999023229A1 A method of inhibiting an immune response to a recombinant vector |
| 05/14/1999 | WO1999023221A2 Multivalent antigen-binding proteins |
| 05/14/1999 | WO1999023220A1 Suppressor of cytokine signaling |
| 05/14/1999 | WO1999023219A1 Human slit polypeptide and polynucleotides encoding same |
| 05/14/1999 | WO1999023217A1 A novel gene and uses therefor |
| 05/14/1999 | WO1999023213A1 Actin-binding polypeptides and nucleic acids encoding the same |
| 05/14/1999 | WO1999023212A1 Novel streptococcal ers |
| 05/14/1999 | WO1999023209A2 ErbB-4 TARGETED RIBOZYMES |
| 05/14/1999 | WO1999023208A2 RIBOZYMES TARGETED TO IL-15 mRNA |
| 05/14/1999 | WO1999023207A1 Monoclonal antibodies to canine cd34 |
| 05/14/1999 | WO1999023201A1 MURD PROTEIN AND GENE OF $i(STREPTOCOCCUS PYOGENES) |
| 05/14/1999 | WO1999023115A1 Glycosylated obesity protein analogs |
| 05/14/1999 | WO1999023114A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 05/14/1999 | WO1999023113A2 Rho family antagonists and their use to block inhibition of neurite outgrowth |
| 05/14/1999 | WO1999023112A1 A FUSION PROTEIN OF hEGF AND HUMAN ANGIOGENIN, AND PROCESS FOR PREPARING THE SAME |
| 05/14/1999 | WO1999023111A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma |
| 05/14/1999 | WO1999023109A2 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| 05/14/1999 | WO1999023108A1 Inducible phosphofructokinase and the warburg effect |
| 05/14/1999 | WO1999023106A1 Caspase-14 polypeptides |
| 05/14/1999 | WO1999023105A1 Vegi, an inhibitor of angiogenesis and tumor growth |
| 05/14/1999 | WO1999023065A1 Hemoglobin with chemically introduced disulfide cross-links and preparation thereof |
| 05/14/1999 | WO1999022773A2 Sequences for targeting metastatic cells |
| 05/14/1999 | WO1999022772A1 LIPOSOMAL OLIGONUCLEOTIDE COMPOSITIONS FOR MODULATING ras GENE EXPRESSION |
| 05/14/1999 | WO1999022765A1 Control of lymphocyte localization by leep-cam activity |
| 05/14/1999 | WO1999022764A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | WO1999022763A2 Encapsulated immunomodulators useful as vaccine adjuvants |
| 05/14/1999 | WO1999022762A1 Tolerogenic fragments of natural allergens |
| 05/14/1999 | WO1999022760A1 Method and compositions for inhibiting angiogenesis and treating cancer |
| 05/14/1999 | WO1999022759A1 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 05/14/1999 | WO1999022758A1 Tri-, tetra-, penta-, and polypeptides and their therapeutic use as an antidepressant agent |
| 05/14/1999 | WO1999022756A1 Cell-permeable protein inhibitors of calpain |
| 05/14/1999 | WO1999022755A1 Use of granulysin as an antimicrobial agent |
| 05/14/1999 | WO1999022754A1 Method for administering acylated insulin |
| 05/14/1999 | WO1999022753A1 Heparin cofactor ii preparations and process for producing the same |
| 05/14/1999 | WO1999022752A1 Composition and method for increasing insulin activity |
| 05/14/1999 | WO1999022744A1 Use of aliphatic polyamines for reducing oxalate |
| 05/14/1999 | WO1999022742A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | WO1999022738A1 Compositions of lipid lowering agents |
| 05/14/1999 | WO1999022729A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 05/14/1999 | WO1999022609A1 System, method and composition for dialysis and shock treatment |
| 05/14/1999 | WO1999014345A3 Medicament for treating a manifested lyme disease |
| 05/14/1999 | WO1999012561A3 FRACTURE HEALING USING PTHrP ANALOGS |
| 05/14/1999 | WO1999011282A9 Compositions and methods for contraception in or sterilization of mammals |
| 05/14/1999 | WO1999011281A9 The use of agents which bind g proteins for treating septic shock |
| 05/14/1999 | WO1999009055A3 Interferon-gamma-binding molecules for treating septic shock, cachexia, immune diseases and skin disorders |
| 05/14/1999 | WO1999008109A3 Antibodies to oxidation-specific epitopes on lipoprotein and methods for their use in detecting, monitoring and inhibiting the growth of atheroma |
| 05/14/1999 | WO1999007839A3 Immunoprotective influenza antigen and its use in vaccination |
| 05/14/1999 | WO1999007835A3 1-alpha-hydroxylase |
| 05/14/1999 | WO1999007739A3 Dna encoding the human synapsin iii gene and uses thereof |
| 05/14/1999 | WO1999005269A8 Transcriptional silencer protein nrf |
| 05/14/1999 | WO1999004752A3 Methods for treating skin pigmentation |
| 05/14/1999 | WO1999004265A8 Cancer associated nucleic acids and polypeptides |
| 05/14/1999 | WO1999003508A9 METHOD FOR TREATING VASCULAR PROLIFERATIVE DISEASES WITH p27 AND FUSIONS THEREOF |
| 05/14/1999 | WO1999002183A3 A method of inducing a ctl response |
| 05/14/1999 | WO1999001764A3 METHOD FOR DETERMINING GnRH RECEPTORS |
| 05/14/1999 | WO1998058965A3 B7-binding molecules for treating immune diseases |
| 05/14/1999 | WO1998053838A3 A soluble laminin receptor precursor and methods to inhibit its interactions |
| 05/14/1999 | WO1998047917A9 A PURIFIED 20 kDa PRESENILIN 2 C-TERMINAL FRAGMENT AND METHODS OF SCREENING FOR COMPOUNDS THAT INHIBIT PROTEOLYSIS OF PRESENILIN 2 |
| 05/14/1999 | WO1998047480A3 Membrane system for controlled tissue regeneration in cases of diseases of the peridontium |
| 05/14/1999 | WO1998033904A3 An antisense oligonucleotide preparation method |
| 05/14/1999 | WO1998014593A9 Human telomerase catalytic subunit |
| 05/14/1999 | CA2309099A1 Erbb-4 targeted ribozymes |
| 05/14/1999 | CA2309005A1 Murd protein and gene of streptococcus pyogenes |
| 05/14/1999 | CA2308852A1 Rnase l activators and antisense oligonucleotides effective to treat rsv infections |
| 05/14/1999 | CA2308637A1 Methods and compositions for targeting dna metabolic processes using aminoglycoside derivatives |
| 05/14/1999 | CA2308610A1 Heparin cofactor ii preparation and process therefor |
| 05/14/1999 | CA2308565A1 Sequences for targeting metastatic cells |
| 05/14/1999 | CA2308438A1 Method and compositions for inhibiting angiogenesis and treating cancer |
| 05/14/1999 | CA2308277A1 Hemoglobin with chemically introduced disulfide cross-links and preparation thereof |
| 05/14/1999 | CA2308136A1 Method for administering acylated insulin |
| 05/14/1999 | CA2308112A1 Caspase-14 polypeptides |
| 05/14/1999 | CA2308091A1 Inducible phosphofructokinase and the warburg effect |
| 05/14/1999 | CA2308029A1 Reagents and methods useful for detecting diseases of the breast |
| 05/14/1999 | CA2308018A1 Ribozymes targeted to il-15 mrna |
| 05/14/1999 | CA2308017A1 A method of inhibiting an immune response to a recombinant vector |
| 05/14/1999 | CA2307839A1 Gene involved in metabolic energy and obesity |
| 05/14/1999 | CA2307805A1 A method for mapping the active sites bound by enzymes that covalently modify substrate molecules |
| 05/14/1999 | CA2307622A1 Muc-1 derivatives and their use in treating cancer-associated muc-1 mucin-induced immunosuppression |
| 05/14/1999 | CA2307560A1 System, method and composition for dialysis and shock treatment |
| 05/14/1999 | CA2307541A1 Encapsulated immunomodulators useful as vaccine adjuvants |
| 05/14/1999 | CA2307380A1 Process for the production of highly viral safe components for forming fibrin glue from a pool of human plasma |
| 05/14/1999 | CA2307166A1 Methods and compositions comprising glycoprotein glycoforms |
| 05/14/1999 | CA2307097A1 Compositions of lipid lowering agents |
| 05/14/1999 | CA2304981A1 Rho family antagonists and their use to block inhibition of neurite outgrowth |
| 05/14/1999 | CA2298475A1 Method of inhibiting side effects of pharmaceutical compositions containing amphiphilic vehicles or drug carrier molecules |
| 05/14/1999 | CA2276685A1 Suppressor of cytokine signaling |
| 05/14/1999 | CA2276013A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock |
| 05/14/1999 | CA2254383A1 Novel fabh |
| 05/12/1999 | EP0915168A1 Process for producing maturation bone morphogenetic protein |
| 05/12/1999 | EP0915164A2 RncS, a ribonuclease from Staphylococcus aureus |
| 05/12/1999 | EP0915162A2 Adenine phosphoribosyltransferase |
| 05/12/1999 | EP0915161A2 DnaG DNA primase of Streptococcus pneumoniae |
| 05/12/1999 | EP0915157A2 Method for the preparation of functional recombinant tissue factor |
| 05/12/1999 | EP0915155A1 Novel signal transducer |